Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by dogwagon May 16, 2013 7:59pm
181 Views
Post# 21405871

BASHERS and GOOD COMPANIES!!!!

BASHERS and GOOD COMPANIES!!!!

Does everyone notice that no one is bashing this stock??They came in at $630.00 cash costs so gold would have to drop dramatically for them to loose money and 95% of the mining  companies could not survive where as BRD could at much lower gold prices.Even with their all in costs probably around $900.00 an ounce they are in a better position than most majors who,s average all in costs are around $1200.00 per ounce.They should be able to ride out the current storm.The Dept ceiling in the U.S. will be reached on May 19th (this is when they run out of money to pay their bills) and the last time that happened,the U.S. got downgraded and gold hit an all time high of $1921.00 per ounce.So a turnaround could be brewing in the gold market!!Food for thought!!

Bullboard Posts